ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Louisiana » Clinical Cardiac Electrophysiology

Top Clinical Cardiac Electrophysiology Prescribers in Louisiana

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
STEVEN GREMILLION M D

Clinical Cardiac Electrophysiology

13,622

$688K

976
852 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

27%
prescriptions for brand name drugs

Avg: 26%

$51
Average prescription price

Avg: $68

NORMAN DEUMITE MD

Clinical Cardiac Electrophysiology

12,343

$554K

904
834 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

22%
prescriptions for brand name drugs

Avg: 26%

$45
Average prescription price

Avg: $68

CHARLES SMITH M.D.

Clinical Cardiac Electrophysiology

8,104

$378K

680
588 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

9%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

22%
prescriptions for brand name drugs

Avg: 26%

$47
Average prescription price

Avg: $68

DAVID BURKETT M.D.

Clinical Cardiac Electrophysiology

5,867

$1M

505
420 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

3%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

43%
prescriptions for brand name drugs

Avg: 26%

$171
Average prescription price

Avg: $68

FREDDY ABI-SAMRA MD

Clinical Cardiac Electrophysiology

3,160

$308K

449
400 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

35%
prescriptions for brand name drugs

Avg: 26%

$97
Average prescription price

Avg: $68

PATRICK WELCH M.D.

Clinical Cardiac Electrophysiology

2,950

$179K

337
281 are 65+

3%
patients receiving schedule two controlled substances

Avg: 0%

12%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

26%
prescriptions for brand name drugs

Avg: 26%

$61
Average prescription price

Avg: $68

JAMES MCKINNIE MD

Clinical Cardiac Electrophysiology

1,712

$143K

360
293 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 26%

$83
Average prescription price

Avg: $68

MURAT CELEBI M.D.

Clinical Cardiac Electrophysiology

1,468

$84.7K

172
147 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 26%

$58
Average prescription price

Avg: $68

DANIEL MORIN MD MPH

Clinical Cardiac Electrophysiology

1,356

$148K

261
222 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

36%
prescriptions for brand name drugs

Avg: 26%

$109
Average prescription price

Avg: $68

RAVI KANAGALA MD

Clinical Cardiac Electrophysiology

1,306

$47.4K

169
132 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

13%
prescriptions for brand name drugs

Avg: 26%

$36
Average prescription price

Avg: $68

SAMMY KHATIB M.D.

Clinical Cardiac Electrophysiology

1,290

$132K

264
236 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

30%
prescriptions for brand name drugs

Avg: 26%

$102
Average prescription price

Avg: $68

GLENN POLIN MD

Clinical Cardiac Electrophysiology

852

$53.9K

148
133 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

27%
prescriptions for brand name drugs

Avg: 26%

$63
Average prescription price

Avg: $68

WILLIAM BAILEY M.D.

Clinical Cardiac Electrophysiology

724

$17.6K

97
86 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

18%
patients receiving schedule three controlled substances

Avg: 3%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

8%
prescriptions for brand name drugs

Avg: 26%

$24
Average prescription price

Avg: $68

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank